简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2015-10-19 16:01 FDA Approves Praxbind® (idarucizumab), Specific Reversal Agent for Pradaxa® (dabigatran etexilate)
2015-10-19 14:26 New CPR Guidelines Recommend Using Social Media and Mobile Technology to Speed Bystander CPR in Sudden Cardiac Arrests
2015-10-16 17:51 GN ReSound and Cochlear Limited Establish Smart Hearing Alliance to Develop and Commercialise Bimodal Solutions
2015-10-16 17:11 One Year on, Allianz Worldwide Care’s MyHealth App Hits 100,000 Member Claim Submissions
2015-10-16 14:15 Quintiles Named 2015 Frost & Sullivan Asia Pacific CRO Company of the Year
2015-10-16 10:04 Adare Pharmaceuticals Appoints James Jogerst as Vice President, Corporate Development
2015-10-15 13:45 Quintiles Recognized as Phase I Services Leader for Third Consecutive Year
2015-10-15 09:55 Joe Kiani to Deliver Keynote Address at Brazil’s Inaugural Foundation for Patient Safety Symposium
2015-10-14 14:37 Cell Signaling Technology Expands Portfolio with GMP Capabilities
2015-10-14 14:27 Jubilant DraxImage launches HICON® in Colombia
2015-10-14 13:25 One Year Data from Phase III Study Evaluating Oral OTEZLA® (apremilast) or Injectable etanercept versus Placebo in Patients with Moderate to Severe Plaque Psoriasis Presented at EADV
2015-10-13 17:37 Olea Medical to Join Toshiba Medical Systems Corporation Group
2015-10-13 15:54 Arcadia Biosciences Receives US Patent for Resistant Starch Wheat Technology
2015-10-13 15:47 Quintiles Wins Society for Clinical Research Sites’ 2015 Eagle Award
2015-10-12 17:39 New Cancer Research Funding Effort Announced by Feld Entertainment and Primary Children’s Hospital
2015-10-12 17:26 Masimo PVI® Evaluated in 18-Study Meta-Analysis for Ability to Help Clinicians Assess Fluid Responsiveness
2015-10-12 16:18 ReSound® Brings Industry-Leading Hearing Aid Portfolio to EUHA 2015
2015-10-12 15:53 Merck and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma
2015-10-12 15:07 Octapharma AG Invests €80 Million to Acquire an Exclusive Worldwide License to Certain IP of Glycotope’s Recombinant Technology and to Become a Minority Shareholder of Glycotope GmbH Berlin
2015-10-12 13:49 Cell Therapy Catapult Launches Cell History File

Business Wire Weibo

Press Releases

Latest Releases